Solid Biosciences is trading 5.6% down at $9.01 after three consecutive lower closes, as major U.S. indices fell more than 0.5% amid hotter producer inflation, elevated oil prices, and higher-for-longer interest-rate concerns.
- No clear negative company-specific announcement was identified for September 10, 2026.
- Management was scheduled to participate in the Citi Biopharma Back to School Conference at 3:00 p.m. ET; the event was not presented as a negative catalyst.